Successful Treatment of Multirefractory Immune Thrombocytopenia in Rubinstein–Taybi Syndrome With Combined Rituximab and Eltrombopag
Abstract
The authors declare no conflicts of interest. Data are available upon request.
Fields of Study & Subjects
Platelet Disorders and Treatments
Immunodeficiency and Autoimmune Disorders
Blood groups and transfusion
Publication details
- Journal / source
- Pediatric Blood & Cancer
- Volume
- 73
- Issue
- 5
- Pages
- e70172–e70172
- Publication date
- 22 February 2026
- Language
- EN